Quantifying the contributions of asymptomatic and symptomatic colonized patients to Clostridioides difficile acquisition in oncological units
Infection Control & Hospital Epidemiology · 2026-11 · 47 (11) · 1108-1114
DOI: 10.1017/ice.2026.10557 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, online erschienen am 01.10.2026. Verfasst von Savannah Curtis und 12 weiteren Autor:innen. Beteiligte Einrichtung: North Carolina State University, Raleigh, USA. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Cross Infection. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NIGMS NIH HHS, NCEZID CDC HHS.
Abstract (Originalsprache)
Objective
Leukemic and hematopoietic cell transplant patients have one of the highest incidences of Clostridioides difficile infection (CDI). Although CDI patients are considered the primary source of transmission, asymptomatic colonized (AC) patients can progress to CDI or contribute to in-unit transmission. We aim to quantify the roles of CDI and AC patients in C. difficile importation and transmission within oncological units.
Design
Prospective cohort study Setting: Two leukemia and hematopoietic cell transplant units in a large tertiary care hospital in the United States for a 6-month period.
Methods
We developed a stochastic, individual-based network model to simulate C. difficile acquisition and transmission. Data from cultures and nucleic acid amplification testing obtained at admission and weekly, and toxin enzyme immunoassay tests used for CDI diagnosis were used to calibrate the model. Healthcare worker room assignments informed the network structure. Key parameters were estimated via particle filtering.
Results
The model reproduced observed weekly test counts and transmission pairs. Only 23% of new colonization events were observed via testing. AC patients were the primary source of new colonizations: 51% (range: 38%–70%) were due to importation (of those, 87% were admitted as AC), and 49% (30%–62%) were due to transmission (AC was the source in 92% of transmissions that resulted in new colonizations).
Conclusions
These findings reinforce the role of AC, particularly via admission importation, in sustaining C. difficile transmission in high-risk hospital settings. Infection control focused on CDI effectively reduced onward transmission, as indicated by CDI’s low contribution to new colonizations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- North Carolina State University, Raleigh, USA.
- Vanderbilt University Medical Center, USA.
- Washington University School of Medicine in Saint Louis: Washington University I, USA.
- The University of Tennessee Knoxville Department of Mathematics, USA.
ORCID-Profile: Savannah Curtis, Emily Struttmann, Margaret Olsen, Sankalp Arya, Cristina Lanzas
Förderung
- NIGMS NIH HHS
- NCEZID CDC HHS
Zitieren
APA
Curtis, S., Lee, M. M., Hink, T., Reske, K. A., Struttmann, E., Iqbal, Z. H., Cass, C., Olsen, M., Arya, S., Burnham, C. A., Lenhart, S., Dubberke, E., & Lanzas, C. (2026). Quantifying the contributions of asymptomatic and symptomatic colonized patients to Clostridioides difficile acquisition in oncological units. Infection Control & Hospital Epidemiology, 47(11), 1108-1114. https://doi.org/10.1017/ice.2026.10557
Vancouver
Curtis S, Lee MM, Hink T, Reske KA, Struttmann E, Iqbal ZH, et al. Quantifying the contributions of asymptomatic and symptomatic colonized patients to Clostridioides difficile acquisition in oncological units. Infection Control & Hospital Epidemiology. 2026;47(11):1108-1114. doi:10.1017/ice.2026.10557
BibTeX
@article{Curtis2026,
author = {Curtis, Savannah and Lee, Mary M and Hink, Tiffany and Reske, Kimberly A and Struttmann, Emily and Iqbal, Zainab Hassan and Cass, Candice and Olsen, Margaret and Arya, Sankalp and Burnham, Carey-Ann and Lenhart, Suzanne and Dubberke, Erik and Lanzas, Cristina},
title = {Quantifying the contributions of asymptomatic and symptomatic colonized patients to Clostridioides difficile acquisition in oncological units},
journal = {Infection Control & Hospital Epidemiology},
year = {2026},
volume = {47},
number = {11},
pages = {1108--1114},
doi = {10.1017/ice.2026.10557}
}
EUVIMED